Chronic Kidney Disease or Hypertension After Childhood Cancer
JAMA Network Open · 2025
DOI: 10.1001/jamanetworkopen.2025.8199 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, 2025. Verfasst von Asaf Lebel und 22 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Hypertension, Neoplasms, Cancer Survivors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR.
Abstract (Originalsprache)
Importance Post–cancer therapy kidney outcomes, including chronic kidney disease (CKD) and hypertension, are common in childhood cancer survivors (CCS). The incidence and timing of CKD and hypertension in CCS compared with other at-risk or general populations are unclear.
Objective
To determine the association of childhood cancer treatment with post–cancer therapy CKD or hypertension. Design, Setting, and Participants Population-based matched cohort study of children treated for cancer between April 1993 and March 2020 in Ontario, Canada, with follow-up until March 2021. The CCS (exposed) cohort included children (≤18 years) surviving cancer. Comparator cohorts were a hospitalization cohort (children who were hospitalized) and a general pediatric population (GP) cohort (all other Ontario children). Exclusion criteria were history of previous cancer, organ transplant, CKD, dialysis, or hypertension. Matching with each of the 2 comparator cohorts was performed separately and in a 1:4 ratio by age, sex, rural vs urban status, income quintile, index year, and presence of previous hospitalization. Data were analyzed from March 2021 to August 2024. Exposure Treatment for cancer. Main Outcomes and Measures The primary outcome was the composite of CKD or hypertension, defined by administrative health care diagnosis and procedure codes. Fine and Gray subdistribution hazard modeling, accounting for competing risks (death and new cancer diagnosis or relapse) and adjusting for cardiac disease, liver disease, and diabetes, was used to determine the association of cancer treatment with outcomes.
Results
There were 10 182 CCS (median [IQR] age at diagnosis, 7 [3-13] years; 5529 male [54.3%]; median [IQR] follow-up time, 8 [2-15] years) matched to 40 728 hospitalization cohort patients (median [IQR] age at diagnosis, 7 [2-12] years; 5529 male [weighted percentage, 54.3%]; median [IQR] follow-up time, 11 [6-18] years) and 8849 CCS (median [IQR] age at diagnosis, 5 [2-11] years; 4825 male [54.5%]; median [IQR] follow-up time, 7 [2-14] years) matched to 35 307 GP cohort individuals (median [IQR] age at diagnosis, 6 [2-11] years; 4825 male [weighted percentage, 54.5%]; median [IQR] follow-up time, 10 [5-16] years). Most frequent cancer types were leukemia (2948 patients [29.0%]), central nervous system neoplasms (2123 patients [20.9%]), and lymphoma (1583 patients [15.5%]). During observation, cumulative incidence of CKD or hypertension was 20.85% (95% CI, 18.75%-23.02%) in the CCS cohort vs 16.47% (95% CI, 15.21%-17.77%) in the hospitalization cohort and 19.24% (95% CI, 15.99%-22.73%) in the CCS cohort vs 8.05% (95% CI, 6.76%-9.49%) in the GP cohort. CCS were at increased risk of CKD or hypertension compared with the hospitalization cohort (adjusted hazard ratio, 2.00; 95% CI, 1.86-2.14; P < .001) and the GP cohort (adjusted hazard ratio, 4.71; 95% CI, 4.27-5.19; P < .001). Conclusions and Relevance In this population-based study, CCS were at increased risk for CKD and hypertension, which are associated with mortality, suggesting that early detection and treatment of these conditions in CCS may decrease late complications and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Nephrology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Pediatric Nephrology Unit, Ha'Emek Medical Center, Afula, Israel.
- Division of Pediatric Nephrology, Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
- Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, Canada.
- Department of Pediatric Hematology and Oncology, McMaster Children's Hospital, Hamilton, Ontario, Canada.
- London Health Sciences Centre, Lawson Health Research Institute, London, Ontario, Canada.
Förderung
- CIHR
Zitieren
APA
Lebel, A., Chanchlani, R., Cockovski, V., Dart, A., Fleming, A. J., Garg, A. X., Jeyakumar, N., Kim, K., Kitchlu, A., McArthur, E., Nash, D., Nathan, P. C., Parekh, R. S., Pearl, R., Pole, J., Ramphal, R., Reid, J., Schechter-Finkelstein, T., Sung, L., …, & Zappitelli, M. (2025). Chronic Kidney Disease or Hypertension After Childhood Cancer. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.8199
Vancouver
Lebel A, Chanchlani R, Cockovski V, Dart A, Fleming AJ, Garg AX, et al. Chronic Kidney Disease or Hypertension After Childhood Cancer. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2025.8199
BibTeX
@article{Lebel2025,
author = {Lebel, Asaf and Chanchlani, Rahul and Cockovski, Vedran and Dart, Allison and Fleming, Adam James and Garg, Amit X and Jeyakumar, Nivethika and Kim, Kirby and Kitchlu, Abhijat and McArthur, Eric and Nash, Danielle and Nathan, Paul C and Parekh, Rulan S and Pearl, Rachel and Pole, Jason and Ramphal, Raveena and Reid, Jennifer and Schechter-Finkelstein, Tal and Sung, Lillian and Wald, Ron and Wang, Stella and Wong, Peter and Zappitelli, Michael},
title = {Chronic Kidney Disease or Hypertension After Childhood Cancer},
journal = {JAMA Network Open},
year = {2025},
doi = {10.1001/jamanetworkopen.2025.8199}
}
EUVIMED